Abstract
CD44, as a superficial cellular glycoprotein, is an essential factor in cell-cell and cell-matrix interaction. The CD44 expression level has been substantially up-regulated in breast cancer, and this upregulation facilitates tumor proliferation and angiogenesis. This study aims to evaluate the combination therapy of Jet Pei/CD44-specific-siRNA/doxorubicin in breast cancer MDA-MB468 cell line. The MTT assay, wound healing test, colony formation assay, DAPI staining, and flow cytometry were performed to investigate the tumoral cell viability, migration, clonogenesis, and apoptosis progression. The quantitative real-time PCR (qRT-PCR) was performed to demonstrate the CD44 expression level. Finally, the effect of CD44 silencing on the expression of VEGF, CXCR4, MMP9, and MiR-142-3p was measured. The combination of CD44-specific-siRNA with doxorubicin decreased tumoral metastasis, proliferation, invasion, and migration, and increased apoptosis in MDA-MB468 cells. In conclusions, CD44 can serve as a therapeutic target in breast cancer. Moreover, the combination therapy of CD44-specific-siRNA with doxorubicin can be a promising treatment for patients with breast cancer.
References
Jan 1, 1993·The Journal of Clinical Investigation·R A BerkmanE H Oldfield
Jan 14, 1999·Genes & Development·Q Yu, I Stamenkovic
Oct 9, 2004·Cancer Gene Therapy·Natalia LaptevaSi-Yi Chen
Dec 3, 2004·Cancer Research·Matthew C P SmithGary D Luker
Jan 11, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joseph F MurphyAideen C Long
May 10, 2006·RNA·Yuriy FedorovAnastasia Khvorova
Jul 11, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M Z DewanN Yamamoto
Nov 18, 2006·Cell·Gaorav P Gupta, Joan Massagué
Jun 30, 2007·Experimental and Molecular Pathology·Venkateswaran SubramaniamSerge Jothy
Dec 7, 2007·Journal of Occupational Medicine and Toxicology·Sarabjeet Singh SuriBaljit Singh
Feb 5, 2008·Cancer Cell·Zhen Fan YangSheung Tat Fan
May 20, 2008·Cell·Sendurai A ManiRobert A Weinberg
Feb 28, 2009·The Journal of Biological Chemistry·Suniti MisraShibnath Ghatak
Mar 24, 2010·International Journal of Nanomedicine·Ying WuGuoda Lian
Aug 13, 2011·Clinical & Experimental Metastasis·Pongsanat PongcharoenRutaiwan Tohtong
Mar 12, 2013·TheScientificWorldJournal·Aditi GuptaMeenakshi A Chellaiah
Oct 5, 2013·Cell Death & Disease·K FuchsV Orian-Rousseau
Jun 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George W SledgeAntonio C Wolff
Aug 2, 2014·Advances in Cancer Research·Véronique Orian-Rousseau, Jonathan Sleeman
Mar 24, 2015·Oncotarget·Yuan GaoKefeng Dou
Apr 24, 2015·Frontiers in Immunology·Véronique Orian-Rousseau
Jan 1, 2014·Breast Cancer Research : BCR·Luciano G MartelottoJorge S Reis-Filho
Oct 16, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Saeed KachalakiBehzad Mansoori
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
May 21, 2016·Stem Cells International·Ranjeeta Thapa, George D Wilson
May 26, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Behzad MansooriBehzad Baradaran
Jun 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shujie ZhaoJames W Freeman
Sep 20, 2016·The International Journal of Biochemistry & Cell Biology·I MorathV Orian-Rousseau
Mar 23, 2017·Frontiers in Cell and Developmental Biology·Linda T Senbanjo, Meenakshi A Chellaiah
Oct 8, 2017·Methods in Molecular Biology·Liang WangDaoyan Wei
Dec 17, 2017·Molecular Therapy. Nucleic Acids·Christin HelmschrodtFranziska Richter
Aug 10, 2018·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fabian M TroschelBurkhard Greve
Oct 27, 2018·Journal of Cellular Physiology·Fatemeh VahidianBehzad Baradaran